FDA Will Withdraw, Wind Down More Than 40 COVID Guidances, Policies

By Beth Wang / March 10, 2023 at 12:49 PM
FDA plans to immediately withdraw or start to wind down 44 COVID-19-related guidances once the public health emergency ends on May 11, including policies related to drug compounding and distribution of drug samples during the PHE, the agency announced Friday (March 10) . The agency also identified 24 guidances it will keep in place beyond the PHE expiration, including those that lay out expectations for the development and licensure of COVID-19 vaccines, explain how FDA conducts remote facility inspections, and...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.